Statin wars: have we been misled about the evidence? A narrative review

M Demasi - British Journal of Sports Medicine, 2018 - bjsm.bmj.com
Statins are the most widely prescribed, cholesterol-lowering drugs in the world. Despite the
expiration of their patents, revenue for statins is expected to rise, with total sales on track to …

[HTML][HTML] Biochemical effects of a diet containing foods enriched with n− 3 fatty acids

…, RA Gibson, MA Neumann, M Demasi… - The American journal of …, 2000 - Elsevier
Background: Results of many studies indicate that consumption of n−3 fatty acids can benefit
persons with cardiovascular disease and rheumatoid arthritis. However, encapsulated fish …

Evaluating the association between low-density lipoprotein cholesterol reduction and relative and absolute effects of statin treatment: a systematic review and meta …

P Byrne, M Demasi, M Jones, SM Smith… - JAMA internal …, 2022 - jamanetwork.com
Importance The association between statin-induced reduction in low-density lipoprotein
cholesterol (LDL-C) levels and the absolute risk reduction of individual, rather than composite, …

[HTML][HTML] COVID-19 and substance use disorders: Recommendations to a comprehensive healthcare response. an international society of addiction medicine practice …

…, M Sadeghi, P Nematollahi, M Demasi… - Basic and Clinical …, 2020 - ncbi.nlm.nih.gov
Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher
morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are …

Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors

PS Penglis, LG Cleland, M Demasi… - The Journal of …, 2000 - journals.aai.org
There is an autocrine relationship between eicosanoid and cytokine synthesis, with the ratio
of prostaglandin E 2 (PGE 2)/thromboxane A 2 (TXA 2) being one of the determinants of the …

Placebo—the unknown variable in a controlled trial

M Demasi, T Jefferson - JAMA Internal Medicine, 2021 - jamanetwork.com
The use of a placebo in controlled trials is essential for the reliable assessment of a therapeutic
drug. Sometimes trialists use an active placebo that can mimic the possible harms of the …

[HTML][HTML] The cholesterol and calorie hypotheses are both dead—it is time to focus on the real culprit: insulin resistance

M Demasi, RH Lustig… - Pharmaceutical …, 2017 - pharmaceutical-journal.com
Illustration showing diabetes and heart disease One of the safest and most effective ways to
reduce the risk of heart attack and stroke is to consume a high fat and low glycaemic load …

From FDA to MHRA: are drug regulators for hire?

M Demasi - bmj, 2022 - bmj.com
Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of
investigational medicines before they hit the market. But do they have sufficient …

Serious harms of the COVID-19 vaccines: a systematic review

PC Gøtzsche, M Demasi - MedRxiv, 2022 - medrxiv.org
Introduction Serious harms of the COVID-19 vaccines have been underreported in published
trial reports. Methods Systematic review of papers with data on serious adverse events (…

[HTML][HTML] COVID-19 and metabolic syndrome: could diet be the key?

M Demasi - BMJ evidence-based medicine, 2021 - ebm.bmj.com
In the current COVID-19 pandemic, governments mandate social distancing and good hand
hygiene, but little attention is paid to the potential impact of diet on health outcomes. Poor …